Clinitech Laboratory Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | July 25, 2024 to July 29, 2024 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Price Band | ₹ 96 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 6,02,400 shares (aggregating up to ₹ 5.78 Cr) |
| Fresh Issue | 6,02,400 shares (aggregating up to ₹ 5.78 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre issue | 16,80,000 |
| Shareholding post issue | 22,82,400 |
| Market Maker portion | 31,200 shares Svcm Securities |
About Clinitech Laboratory Limited IPO
Clinitech Laboratory is a provider of diagnostic and healthcare tests and services through a chain of 8 diagnostic centers in and around Thane and Navi Mumbai. Their Promoters have 30+ years of experience in the diagnostic business. They conduct more than 3 Lakh tests per year in their NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment.
Clinitech Laboratory IPO is a fixed price issue of Rs 5.78 crores. The issue is entirely a fresh issue of 6.02 lakh shares. Clinitech Laboratory IPO opens for subscription on July 25, 2024 and closes on July 29, 2024. Clinitech Laboratory's IPO price is ₹96 per share. The minimum lot size for an application is 1200 Shares. Inventure Merchant Banker Services Pvt Ltd is the book-running lead manager of the Clinitech Laboratory IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for the Clinitech Laboratory IPO is Svcm Securities.
Clinitech Laboratory IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 50% of the Net Issue |
| Other Shares Offered | 50% of the Net issue |
Company & Financials
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services. The company performs more than 150 tests in its centers, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests. Clinitech Laboratory has eight diagnostic centers around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high-quality equipment. The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
Objectives of Clinitech Laboratory IPO
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objectives:
- 1. Expansion of Diagnostic Centres.
- 2. General Corporate Purposes.
Clinitech Laboratory IPO Review
The company is operating in a highly competitive and fragmented segment. It marked almost static top lines for the reported periods and boosted the bottom line for FY24. Based on FY24 super earnings, the issue is exorbitantly priced. There is no harm in skipping this risky bet.
Clinitech Laboratory Limited IPO Financial Information
Latest Revenue
₹ 643.92 Cr
Profit After Tax
₹ 37.12 Cr
Net Worth
₹ 354.80 Cr
Total Borrowing
₹ 86.31 Cr
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31 Mar 2024 | 560.79 | 643.92 | 37.12 | 354.80 | 86.31 |
| 31 Mar 2023 | 603.33 | 636.34 | 61.31 | 238.08 | 102.91 |
| 31 Mar 2022 | 368.74 | 645.70 | 51.26 | 184.81 | 88.61 |
| 31 Mar 2021 | 273.32 | 459.63 | 40.24 | 139.03 | 53.67 |
| Amount in ₹ Crore | |||||
Clinitech Laboratory Limited Key Performance Indicator
| KPI | Values |
|---|---|
| Debt/Equity | 0.24 |
| RoNW | 10.46% |
| P/BV | 4.55 |
| PAT Margin (%) | 5.76 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 2.21 | 1.63 |
| P/E (x) | 43.45 | 59.03 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The INDIA IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Download regulatory filings
Clinitech Laboratory Limited IPO Timeline
| IPO Open Date | Thursday, July 25, 2024 |
| IPO Close Date | Monday, July 29, 2024 |
| Basis of Allotment | Tuesday, July 30, 2024 |
| Initiation of Refunds | Wednesday, July 31, 2024 |
| Credit of Shares to Demat | Wednesday, July 31, 2024 |
| Listing Date | Thursday, August 1, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹ 1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹ 1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹ 2,30,400 |